Sexual counselling for patients with cardiovascular disease: protocol for a pilot study of the CHARMS sexual counselling intervention. by Murphy, Patrick J et al.
Royal College of Surgeons in Ireland
e-publications@RCSI
Psychology Articles Department of Psychology
1-1-2016
Sexual counselling for patients with cardiovascular
disease: protocol for a pilot study of the CHARMS
sexual counselling intervention.
Patrick J. Murphy
NUI Galway
Jenny Mc Sharry
NUI Galway
Dympna Casey
NUI Galway
Sally Doherty
Royal College of Surgeons in Ireland, sallydoherty@rcsi.ie
Paddy Gillespie
NUI Galway
See next page for additional authors
This Article is brought to you for free and open access by the Department
of Psychology at e-publications@RCSI. It has been accepted for inclusion
in Psychology Articles by an authorized administrator of e-
publications@RCSI. For more information, please contact epubs@rcsi.ie.
Citation
Murphy PJ, McSharry J, Casey D, Doherty S, Gillespie P, Jaarsma T, Murphy AW, Newell J, O'Donnell M, Steinke EE, Toomey E,
Byrne M. Sexual counselling for patients with cardiovascular disease: protocol for a pilot study of the CHARMS sexual counselling
intervention. BMJ Open. 2016;6(6):e011219.
Authors
Patrick J. Murphy, Jenny Mc Sharry, Dympna Casey, Sally Doherty, Paddy Gillespie, Tiny Jaarsma, Andrew W.
Murphy, John Newell, Martin O'Donnell, Elaine E. Steinke, Elaine Toomey, and Molly Byrne
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/psycholart/102
— Use Licence —
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/psycholart/102
Sexual counselling for patients with
cardiovascular disease: protocol
for a pilot study of the CHARMS
sexual counselling intervention
Patrick J Murphy,1 Jenny Mc Sharry,1 Dympna Casey,2 Sally Doherty,3
Paddy Gillespie,4 Tiny Jaarsma,5 Andrew W Murphy,6 John Newell,7
Martin O’Donnell,7 Elaine E Steinke,8 Elaine Toomey,9 Molly Byrne1
To cite: Murphy PJ,
Mc Sharry J, Casey D, et al.
Sexual counselling for
patients with cardiovascular
disease: protocol for a pilot
study of the CHARMS
sexual counselling
intervention. BMJ Open
2016;6:e011219.
doi:10.1136/bmjopen-2016-
011219
▸ Prepublication history and
additional material is
available. To view please visit
the journal (http://dx.doi.org/
10.1136/bmjopen-2016-
011219).
Received 20 January 2016
Revised 4 April 2016
Accepted 21 April 2016
For numbered affiliations see
end of article.
Correspondence to
Patrick J Murphy;
murphyp@nuigalway.ie
ABSTRACT
Introduction: Sexual problems are common with
cardiovascular disease, and can negatively impact
quality of life. To address sexual problems, guidelines
have identified the importance of sexual counselling
during cardiac rehabilitation, yet this is rarely provided.
The Cardiac Health and Relationship Management and
Sexuality (CHARMS) intervention aims to improve the
provision of sexual counselling in cardiac rehabilitation
in Ireland.
Methods and analysis: This is a multicentre pilot
study for the CHARMS intervention, a complex,
multilevel intervention delivered within hospital-based
cardiac rehabilitation programmes. The intervention
includes (1) training in sexual counselling for staff, (2)
a staff-led patient education and support intervention
embedded within the cardiac rehabilitation programme,
(3) a patient information booklet and (4) an awareness
raising poster. The intervention will be delivered in two
randomly selected cardiac rehabilitation centres. In
each centre 30 patients will be recruited, and partners
will also be invited to participate. Data will be collected
from staff and patients/partners at T1 (study entry),
T2 (3-month follow-up) and T3 (6-month follow-up).
The primary outcome for patients/partners will be
scores on the Sexual Self-Perception and Adjustment
Questionnaire. Secondary outcomes for patients/
partners will include relationship satisfaction;
satisfaction with and barriers to sexual counselling in
services; sexual activity, functioning and knowledge;
physical and psychological well-being. Secondary
outcomes for staff will include sexuality-related
practice; barriers to sexual counselling; self-ratings of
capability, opportunity and motivation; sexual attitudes
and beliefs; knowledge of cardiovascular disease and
sex. Fidelity of intervention delivery will be assessed
using trainer self-reports, researcher-coded audio
recordings and exit interviews. Longitudinal feasibility
data will be gathered from patients/partners and staff
via questionnaires and interviews.
Ethics and dissemination: This study is approved
by the Research Ethics Committee (REC) of the
National University of Ireland, Galway. Findings will be
disseminated to cardiac rehabilitation staff, patients/
partners and relevant policymakers via appropriate
publications and presentations.
INTRODUCTION
Cardiovascular diseases are the most
common cause of morbidity and death glo-
bally.1 Sexual problems are more prevalent
among individuals with cardiovascular
disease than among the general popula-
tion.2 3 Sexual problems negatively impact
quality of life, psychological well-being and
relationship satisfaction.4 5 Sexual problems
also impact patients’ partners who rate
sexual concerns as one of the most prevalent
stressors.6
Reasons for the association between cardio-
vascular disease and sexual problems include
physical vascular causes,7 fear of sexual
Strengths and limitations of this study
▪ Our study focuses on an under-researched, sen-
sitive and important area of healthcare provision:
sexuality and the provision of sexual counselling.
▪ This pilot study protocol for our sexual counsel-
ling intervention in cardiac rehabilitation is based
on significant exploratory research, recently pub-
lished international guidelines for best practice in
sexual counselling and the latest guidance on
the development of complex interventions.
▪ The intervention is comprehensive (targeting
cardiac rehabilitation staff as well as patients and
their partners), and has been designed to be
integrated sustainably into usual care.
▪ The protocol includes a thorough evaluation of
feasibility and acceptability for the sexual coun-
selling intervention using multiple complimentary
methods.
▪ Self-selection bias into the pilot study may influ-
ence assessments of feasibility and acceptability
for the intervention.
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activity provoking cardiac symptoms or a cardiac event,8
patient/partner relationship changes following a cardiac
event9 and associations with psychological problems
such as depression.10 Sexual side effects of cardiac medi-
cations have been indicated, but recent research is less
conclusive.11 12
A consensus document endorsed by the American
Heart Association and the European Society of
Cardiology recommends that all patients with cardiovas-
cular disease be assessed for sexual concerns and offered
sexual counselling as part of cardiac rehabilitation.12 13
Despite this endorsement and the fact that most people
with cardiovascular disease are interested in receiving
sexual education and counselling,14 sexual problems are
rarely addressed during cardiac rehabilitation.15
How to best implement sexual counselling in cardiac
rehabilitation is as yet uncertain. Very few trials in this
area have been reported. There is some evidence that a
highly intensive intervention (ie, 5 hours of sexual
therapy provided by a sex therapist) can reduce the time
taken to resume sexual activity following a cardiac event,
and improve self-reported sexual function and satisfac-
tion.16 However, it is unlikely that this type of intervention
could be implemented as part of routine cardiac rehabili-
tation in most healthcare systems due to time and
resource limits. Randomised controlled trials (RCTs) of
time-efﬁcient interventions are, therefore, needed.17
The CHARMS baseline study
The Cardiac Health and Relationship Management and
Sexuality (CHARMS) baseline study conducted by the
current research team examined the prevalence and
treatment of sexual problems among patients (N=382)
attending cardiac rehabilitation in Ireland.18 The
CHARMS baseline study reported a high prevalence of
sexual problems—sexual dysfunction was reported by
47% of sexually active male patients and 37% of sexually
active female patients. Almost half (47%) of all patients
surveyed reported no sexual activity in the previous year,
nearly double the rate for an age-matched non-cardiac
sample.19 Less than one-third (29%, n=114) of patients
reported that sexual issues had been addressed in the
cardiac rehabilitation programmes; among these
patients, satisfaction with this aspect of the service was
relatively low. Almost half of all patients (48%, n=183)
would have liked more opportunity to discuss sexual
issues with health professionals.
The CHARMS baseline study also surveyed nationally
representative samples of general practitioners and
cardiac rehabilitation staff. Health professionals seldom
discussed sexual issues with patients, lacked awareness,
knowledge and conﬁdence in this area, and wanted
more training and speciﬁc treatment guidelines.20 21
Finally, the CHARMS baseline study included focus
groups with cardiac rehabilitation patients and staff.14
Analysis of these focus groups supported the results
from the quantitative surveys, highlighting the discon-
nect between the identiﬁed need for support for sexual
issues among patients, and the low level of service provi-
sion reported by staff. The possible components of a
sexual counselling intervention were modelled. Staff
were welcoming of additional training in sexual counsel-
ling guidelines, and patients were welcoming of the
inclusion of support for sexual issues as a routine part of
the cardiac rehabilitation programme.
Development of the CHARMS intervention
Using the Behaviour Change Wheel (BCW) framework
for the design and evaluation of behaviour change inter-
ventions,22 the results from the CHARMS baseline study
were used to develop the CHARMS intervention. This is a
complex, multilevel intervention designed to increase
the provision of sexual assessment and counselling in
cardiac rehabilitation, and improve sexuality-related out-
comes for patients with cardiac disease. It is delivered as
an integrated element of hospital-based cardiac rehabili-
tation, and it addresses the main barriers to the provision
of sexual counselling that were previously identiﬁed. The
intervention includes (1) training and support for
cardiac rehabilitation staff, (2) a staff-led patient interven-
tion, (3) a patient information booklet and (4) an aware-
ness raising poster for display in cardiac rehabilitation
centres. The details of the development of the CHARMS
intervention using the BCW, and details of the speciﬁc
behaviour change techniques (BCTs) associated with
those components, are described elsewhere (McSharry J,
Murphy PJ, Byrne M. Developing the CHARMS interven-
tion to improve implementation of sexual assessment
and counselling in hospital cardiac rehabilitation.
Implementation Science, under review). An example of a
summary mapping of BCTs and intervention components
is provided in the online supplementary ﬁle. The ﬁna-
lised intervention components are described in detail
below under the section ‘Intervention procedures’.
The CHARMS pilot study
The most recent guidance from the Medical Research
Council (MRC) in relation to complex interventions
advises a ‘development-evaluation-implementation’
process.23 The development and piloting phases of trials
are commonly skipped or minimised, with researchers
proceeding directly to RCTs of newly developed inter-
ventions.24 This practice has been identiﬁed as contrib-
uting to the failure of many clinical trials to deliver
conclusive results due to “[p]oor design choices, low
levels of recruitment, signiﬁcant attrition, lack of inter-
vention ﬁdelity, and interventions unacceptable to those
delivering or receiving [them]”.24 Pilot studies are essen-
tial in assessing the acceptability and feasibility of inter-
ventions and study protocols; these help to avoid the
cost of failed trials.25 Accordingly, the aim of the
CHARMS pilot study is to gather and analyse acceptabil-
ity and feasibility data that will allow for (1) the reﬁne-
ment of the CHARMS intervention, and (2) the
development of a deﬁnitive cluster RCT protocol to test
this intervention.
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Speciﬁcally, the CHARMS pilot study will answer the fol-
lowing key research questions:
1. What is the likely effect size for the primary outcome
among patients?
2. What is the optimal number of cardiac rehabilitation
centres (clusters) and cardiac rehabilitation patients
(participants) needed for a deﬁnitive cluster RCT?
A. What are the recruitment and attrition rates for
clusters and participants?
B. What is an unbiased estimate of the intracluster
correlation coefﬁcient for the primary outcome
among participants?
3. Is the intervention both feasible and acceptable?
A. Are the intervention components acceptable to
staff and patients?
B. Are the outcome measures acceptable to staff
and patients?
C. Will the intervention be delivered as designed
(ie, can ﬁdelity be assured)?
METHODS AND ANALYSIS
Design
The CHARMS pilot study is a multicentre feasibility
study. In line with MRC guidance, the CHARMS pilot
study will not be a ‘scale model’ of a deﬁnitive cluster
RCT. However, the pilot will provide data that will
‘address the main uncertainties that have been identi-
ﬁed in the development work’,23 and meet the aims and
objectives outlined above. The CHARMS intervention
will be implemented in two cardiac rehabilitation
centres (clusters) in Ireland. At the cluster level, a
‘CHARMS Educator’ will deliver the CHARMS staff
intervention, consisting of training and support for
cardiac rehabilitation staff in the provision of sexual
counselling to patients. At the participant level, trained
cardiac rehabilitation staff will deliver education and
support to patients and their partners. Following a
repeated-measures design, quantitative and qualitative
data will be gathered from staff, patients and partners at
entry to the study T1 (baseline, preintervention assess-
ment), at T2 (3 months after entry to the study, ﬁrst
postintervention assessment), and at T3 (6 months after
entry to the study, second postintervention assessment).
Participants
Inclusion criteria for cardiac rehabilitation centres
There are 37 cardiac rehabilitation centres in the
Republic of Ireland.26 Each of these centres operates as
a unit within a hospital and most, but not all, offer
phase III cardiac rehabilitation (ie, initial outpatient
cardiac rehabilitation). While phase III cardiac rehabili-
tation programmes vary by centre, generally these start
within 4–6 weeks of the patient’s discharge from hospital
and involve a rehabilitation programme of twice-weekly
supervised exercise and group-based educational ses-
sions on various topics related to living with cardiovascu-
lar disease. Programmes usually last for 8 weeks. Eligible
centres for inclusion in the CHARMS pilot study will
offer phase III cardiac rehabilitation, and will have a
minimum of 80 patients attending rehabilitation per
year (to ensure sufﬁcient patient recruitment).
Inclusion criteria for cardiac rehabilitation patients
Eligible patients will be aged 18 years or older, will have
cardiovascular disease and will be enrolled in phase III
cardiac rehabilitation in the participating centres.
Diagnosis of cardiovascular disease will not be con-
ﬁrmed from medical records as the patients cannot
enrol into the cardiac rehabilitation programme without
such a diagnosis. Eligible patients will be invited to par-
ticipate in the study at enrolment to the cardiac rehabili-
tation programme. Sexual inactivity before entering
cardiac rehabilitation will not be an exclusion criterion
as previous behaviour is not an accurate predictor of
future sexual behaviour or need for information,27 and
even sexually inactive older adults and those who may be
very ill value sexuality as an important part of life and
health.28 Similarly, patients who do not have a current
partner will not be excluded from participation as
sexual self-satisfaction is an important part of sexual
health for all people, regardless of relationship status.29
Sample size calculations
A function of the CHARMS pilot study is to gauge the
feasibility of recruiting a sufﬁcient number of clusters
and participants for a deﬁnitive cluster RCT. Sample size
calculations for this pilot are, therefore, based on calcu-
lations for the envisaged deﬁnitive trial, and a summary
of the latter are presented here. The primary outcome
for the deﬁnitive trial will be the Sexual Self-Perceptions
and Adjustment Questionnaire (SSPAQ) which has been
developed by Steinke et al30 to measure psychosexual
outcomes among cardiac patients. Given the absence of
normative data for the Irish cardiac population to use as
the base for an estimate of effect size for the SSPAQ,
provisional sample size calculations for the deﬁnitive
trial were based on normative data for a US cardiac
sample.30 Based on this normative data, for the deﬁni-
tive trial, it is expected that a total of ﬁve clusters, each
containing 22 participants randomly allocated per arm
(n=220), will be needed in order to have 80% power
(α=0.05) to detect a difference in mean improvement of
10 units between the controls and those receiving the
intervention, assuming a SD of 21 units in 6-month
SSPAQ improvement in both arms and an intracluster
correlation of 0.05. Note that the trial is feasible as the
total number of clusters, that is, 10, is greater than nl×r
(142×0.05)=7, where nl is the number of participants
needed under individual randomisation and r is the esti-
mated intracluster correlation coefﬁcient.31 To allow for
estimated loss to follow-up of 30% of patient partici-
pants,32 and the possibility that one cluster will drop out
of each arm of the trial, 29 patient participants should
be recruited in each centre, and one additional centre
should be recruited and randomised to each arm.
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Therefore, for the deﬁnitive trial, initial estimates are
that 348 patient participants should be recruited from
12 centres (6 centres in the intervention arm, and 6
centres in the control arm).
For the CHARMS pilot study, the number of patient
participants recruited in each pilot centre will be slightly
higher than the calculations for the deﬁnitive trial. One
additional patient participant will be recruited in each
pilot centre, bringing the total in each centre to 30. This
slight increase is based on Viechtbauer et al’s33 formula
for the minimum sample size needed to detect unfore-
seen problems in a pilot study that will have a probability
of occurring of 0.05. As previously mentioned, patients’
partners will also be invited to participate, in line with
guidance on sexual assessment and counselling in
cardiac rehabilitation.13 The research team will docu-
ment the number of centres and the number of patients
invited to achieve the required sample size, the numbers
retained for analysis during the pilot and the time
needed for recruitment.
Recruitment
Centre recruitment
All eligible centres listed in the directory of the Irish
Association of Cardiac Rehabilitation26 will be invited to
participate in the pilot. While the pilot is not a scale
model of a cluster RCT, the invitation to participate in
the pilot will mimic that of a full cluster RCT. In particu-
lar, it will specify that not all consenting centres will be
offered the intervention. By inviting all eligible centres
and by mimicking invitations to a full cluster RCT, we
will obtain informative data on the feasibility of recruit-
ing a sufﬁcient number of centres to the deﬁnitive trial.
We will document the number of centres that accept the
invitation. Reasons for non-acceptance will also be
documented.
We will stratify the consenting centres by location (in
Dublin vs outside Dublin), and implement the pilot in
one centre randomly selected from each stratum. This
stratiﬁcation strategy has been selected as Dublin
accounts for one-quarter of the population of the
Republic of Ireland, and Dublin differs from the rest of
the country in terms of cultural, ethnic and religious
diversity.34 All non-selected consenting centres will be
invited to defer participation to the deﬁnitive trial
(pending funding).
Healthcare professional recruitment
All health professionals at the selected centres will be
invited to participate in the study. Study materials (invi-
tation letters, information sheets, consent forms, ques-
tionnaires) will be given to the cardiac coordinator in
each cardiac rehabilitation team by the CHARMS study
researcher for distribution to his or her team, and will
be returned directly to the CHARMS study researcher in
two stamped addressed envelopes (the consent form
and the questionnaire will be returned in separate envel-
opes to protect conﬁdentiality). Staff members who do
not wish to participate will be provided with the option
of returning an opt-out card, which will allow for indica-
tion of reasons for non-participation. Data related to
participation rates and reasons for non-participation will
be recorded.
Patient recruitment
The cardiac coordinator at each participating centre will
post study materials (invitation letters, information
sheets, consent forms, questionnaires) to patients and
partners starting phase III cardiac rehabilitation.
Recruitment by post was deemed appropriate for two
reasons. First, it would not put undue pressure on
patients to participate in a potentially sensitive study.
Second, as staff will for the most part be unaware if indi-
vidual patients are participating in the study, it will help
to minimise any conscious or unconscious differences in
the treatment of patients based on participation.
Patients and partners will be asked to give consent to
data collection only—as the CHARMS intervention is
being delivered at centre level as a component of existing
cardiac rehabilitation programmes. Consent forms and
completed questionnaires will be returned directly to the
CHARMS study researcher in stamped addressed envel-
opes (the consent form and the questionnaire will be
returned in separate envelopes to protect conﬁdential-
ity). Patients and partners who do not wish to participate
will be provided with the option of returning an opt-out
card, which will also allow for indication of reasons for
non-participation. Data related to participation rates and
reasons for non-participation will be recorded.
Intervention procedures
The CHARMS staff intervention
All staff at the participating centres will be invited to
attend the CHARMS staff intervention, which will be
delivered by a CHARMS Educator using a predeveloped
manual, and will last for ∼2 hours. The CHARMS staff
intervention will include the following components: (1)
welcomes, introductions and an initial outline of the
nature of the CHARMS intervention; (2) rationale for
the CHARMS intervention and introduction to inter-
national sexual counselling guidelines;13 (3) developing
and practising of the sexual counselling skills; (4) an
introduction to the CHARMS patient intervention; (5)
creating an implementation plan for the CHARMS
patient intervention, including nominating a staff
member to deliver the patient intervention, and identify-
ing and addressing barriers to implementation; (6) ques-
tions and answers. The CHARMS Educator will
document the details of the implementation plan, and
report the same to the research team. An example of
the summary mapping of BCTs and intervention compo-
nents is provided in the online supplementary ﬁle.
The CHARMS patient intervention
All patients will attend a structured intervention embed-
ded into their cardiac rehabilitation programme (ie, as
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an additional group-based educational session) which
will include (1) information on the impact of cardiovas-
cular disease on sexuality; (2) information regarding a
healthy sex life and communication strategies for use
with a partner; (3) counselling on risks and fears regard-
ing sex for people living with cardiovascular disease; (4)
tips and strategies for resuming sex after a cardiac event,
and for addressing sexual problems; (5) an invitation to
request a one-to-one consultation and (6) time for ques-
tions and answers. The CHARMS patient intervention
will be delivered by a member of the cardiac rehabilita-
tion staff using a predeveloped manual, and will last for
30 min. Partners of patients will also be invited to attend
the intervention in line with international guidelines on
the provision of sexual counselling, although it is
acknowledged that some patients may prefer to attend it
alone.
A patient information booklet will also be provided to
patients. This booklet will contain information on the
resumption of sexual activity after a cardiac event, and
suggestions about how to deal with problems when they
arise. Study posters will also be displayed in the partici-
pating clinics to reassure patients that a return to sexual
activity after a cardiac event is normal, and encouraging
patients to seek advice from staff if they have a sexual
problem.
Data collection
When selected cardiac rehabilitation centres are
recruited to the study, the research team will meet with
cardiac rehabilitation staff to agree on how and when
the CHARMS intervention will be delivered within their
centre.
All quantitative study data will be gathered using
printed questionnaires, which will be administered to
participating health professionals, patients and partners.
We will collect data at T1 (enrolment in cardiac rehabili-
tation/entry to the study), at T2 (3 months after entry to
the study) and at T3 (6 months after entry to the study).
Assessment at T2 will allow for detection of changes in
measured outcomes postcompletion of the cardiac
rehabilitation programme incorporating the CHARMS
intervention. Assessment at T3 will allow for detection of
persistence of these changes, and for detection of
changes which may require a longer interval to occur.
Staff questionnaires
The measures below will be included in the staff question-
naire. All measures will be administered at T1, T2 and T3
(with the exception of demographic and professional
background which will only be administered at T1).
Demographic and professional information: To include
gender, age, profession, length of employment within
cardiac rehabilitation, employment basis (full-time, part-
time, other), whether the staff member is the cardiac
coordinator, and details of employment in other cardiac
rehabilitation centres.
Sexuality-related practice: To include the amount of time
in the preceding 3 months devoted to sexual counselling
activities, use of referrals to other services for the treat-
ment of sexual problems, use of sexual counselling
guidelines and perception of effectiveness with regard to
sexual issues.
Barriers to discussing sexual problems: Adapted from
Doherty et al,21 this measure includes 17 potential bar-
riers to the provision of sexual counselling in cardiac
rehabilitation (eg, I do not have enough time to discuss
sexual problems). Responses are indicated on a Likert
scale ranging from 1 (strongly disagree) to 5 (strongly
agree).
Ratings of knowledge, awareness and conﬁdence: Adapted
from Doherty et al,21 this measure includes three ques-
tions assessing knowledge, awareness and conﬁdence in
relation to the provision of sexual counselling (eg, How
would you rate your awareness in dealing with sexual
problems with cardiac rehabilitation patients?).
Responses are indicated on a Likert scale ranging from
1 (poor) to 5 (excellent).
Sexual attitudes and beliefs: Adapted from Magnan et al35
to be speciﬁc to cardiac rehabilitation, this measure
includes 12 potential beliefs that staff may hold about
the provision of sexual counselling (eg, Most cardiac
rehab patients are too sick to be interested in sexuality).
Responses are indicated on a Likert scale ranging from
1 (strongly disagree) to 6 (strongly agree).
The Sex after Myocardial Infarction Knowledge Test: The
Sex after Myocardial Infarction Knowledge Test
(SMIKT), developed by Steinke and Swan,36 includes 25
statements about the resumption of sex in the aftermath
of a myocardial infarction (eg, Some medicines used for
high blood pressure, anxiety or depression can affect
sex). Possible responses to each statement are true, false
and don’t know.
Capability, opportunity and motivation: Informed by the
BCW,22 this novel measure includes 10 items related to a
staff member’s self-rated capability, opportunity and
motivation to provide sexual counselling to patients
(eg, It is my responsibility to provide sexual counselling
to my patients). Responses are indicated on a Likert scale
ranging from 1 (strongly disagree) to 6 (strongly agree).
Feedback: Staff members will be invited to indicate the
length of time it took to complete the questionnaire,
and to provide any comments they have about participa-
tion in the study.
Patient questionnaires
The measures below will be included in the patient
questionnaire. All measures will be administered at T1,
T2 and T3. The same measures will be administered to
partners, and at the same time points.
Demographic and medical information: To include gender,
age, use of tobacco products, educational attainment,
sexual orientation, cardiovascular diagnoses and proce-
dures, relationship status, availability of health insurance,
length of time since a cardiac event, use of sexual
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performance medications (eg, sildenaﬁl) and use of car-
diovascular medications.
The Sexual Self-Perception and Adjustment Questionnaire:
The primary outcome for the study. Developed by
Steinke et al,30 this 28-item measure assesses sexual
anxiety, sexual depression, sexual self-efﬁcacy, sexual sat-
isfaction and overall adjustment (eg, I am worried about
having sexual activity). Responses are indicated on a
Likert scale ranging from 1 (never) to 5 (always).
Health-related quality of life: Quality-adjusted life years
associated with health state will be measured using the
standardised EQ-5D-5L,37 which includes assessments of
mobility, self-care, usual activities, pain/discomfort and
anxiety/depression.
Cardiovascular-speciﬁc health-related quality of life:
Developed speciﬁcally for patients with angina, myocar-
dial infarction or ischaemic heart failure, this measure
comprises 14 items assessing physical, emotional and
global health-related quality of life (eg, In the last
4 weeks, have you been bothered by having to lift or
move heavy objects?). Responses are indicated on a scale
ranging from no to a lot.
Sexual activity and sexual problems: Adapted from
Doherty et al,21 this measure includes assessments of the
number of sexual partners, frequency of sex, desire for
sex, presence of sexual problems and the use of profes-
sional services to address sexual problems.
Depression: Depressed mood and anhedonia will be
measured using the 2-item Patient Health Questionnaire
(PHQ-2),38 a widely used screening tool for depression.
Relationship satisfaction: Perceptions of relationship satis-
faction will be assessed using the ENRICH scale.39 This is a
25-item scale (eg, My partner and I understand each other
perfectly), with responses indicated on a Likert scale
ranging from 1 (strongly disagree) to 5 (strongly agree).
Barriers to discussing sexual problems: Adapted from
Doherty et al,21 this measure includes 14 potential bar-
riers to the discussion of sexual issues with healthcare
providers during cardiac rehabilitation (eg, Cardiac
rehab staff do not have enough time to discuss sexual
problems). Responses are indicated on a Likert scale
ranging from 1 (strongly disagree) to 6 (strongly agree).
The Sex after Myocardial Infarction Knowledge Test: As
described above.
The International Index of Erectile Function: Male sexual
function will be assessed with the 15-item International
Index of Erectile Function (IIEF; eg, How do you rate
your conﬁdence that you could get and keep an erec-
tion?).40 The IIEF assesses ﬁve domains of male sexual
function: erectile function, orgasmic function, sexual
desire, intercourse satisfaction and overall satisfaction.
The Female Sexual Function Index: Female sexual func-
tion will be assessed with the 19-item Female Sexual
Function Index (FSFI; eg, Over the past 4 weeks, how
would you rate your level (degree) of discomfort or pain
during or following vaginal penetration?). The FSFI
assesses six domains of female sexual function: desire,
arousal, lubrication, orgasm, satisfaction and pain.
Feedback: Patients and partners will be invited to indi-
cate the length of time it took to complete the question-
naire, and to provide any comments they have about
participation in the study.
Pilot evaluation
Health economic analysis
Without randomisation of centres to intervention and
control arms of a trial, it is not possible to pilot a full
economic evaluation whereby the costs and outcomes of
alternative healthcare interventions are compared to
determine cost-effectiveness.41 Instead, a cost-outcome
description will be undertaken alongside the CHARMS
pilot to examine the costs and outcomes of delivering
the deﬁnitive intervention.41 The analysis will be under-
taken in a manner consistent with the guidelines issued
by the Health and Information Quality Authority in
Ireland.42 Evidence will be collected on resource use
and outcome measures at all time points of the pilot via
patient questionnaires and other study data collection
forms. With respect to costing, a publicly funded health
service perspective will be adopted. Resource use asso-
ciated with delivery of the intervention will be measured
and costed, as will other resource use by patients over
the course of the pilot study. In particular, the cost of
intervention delivery will include costs relating to
CHARMS Educator time input, production of training
manuals, training room rental, rehabilitation staff time
input and CHARMS patient consultations. Other
resource use to be captured will include usage of medi-
cations, and attendance to primary care, community
care and hospital care services over the course of the
pilot study. Unit costs will be applied to convert data on
resource use to resource costs, and a total cost variable
will be calculated. The economic analysis will focus on
the following two outcomes: (1) the primary outcome of
the Sexual Self-Perception and Adjustment
Questionnaire (SSPAQ) score; and (2) the economic
outcome of quality-adjusted life years (QALY). The
QALYs variable will be estimated using the EuroQol
EQ-5D-5L survey instrument which will be completed by
patients at all time points.37 The statistical analysis will
explore the impact of the CHARMS intervention on the
total cost and both outcome variables over the course of
the pilot study. It will examine whether the CHARMS
intervention is associated with an increase or decrease in
total costs, and will further examine whether this is
related to an increase or decrease in outcomes.
Uncertainty in the analysis will be examined using a
combination of standard statistical inference techniques,
and univariate and multivariate sensitivity analyses.
Evaluation of fidelity
Fidelity of the CHARMS pilot study will be assessed
using the guidance provided by the National Institute of
Health’s Behaviour Change Consortium.43 Fidelity
assessment will provide valuable information on the
feasibility of the intervention implementation, as well as
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information on the acceptability and usefulness of the
ﬁdelity assessment procedures which may require adap-
tation for the deﬁnitive intervention.23
Fidelity of the CHARMS staff intervention: A checklist will
be developed for the distinct components of the staff
intervention. The CHARMS Educator will review the
checklist before delivering the staff intervention (as a
reminder of the components to be delivered), and then
complete the checklist after delivering the staff interven-
tion (as a self-report of components actually delivered).
Given that self-reported ﬁdelity can be unreliable,44 an
additional more objective method of assessment of the
staff intervention will be audio recorded and the record-
ing later independently coded by two members of the
research team for the presence of the distinct compo-
nents of the intervention, and also the associated BCTs
used by the CHARMS Educator during delivery.45
The planned intervention components will be
compared with those reported as delivered by the
CHARMS Educator, and those coded as delivered by the
researchers.46 Similarly, the planned BCTs will be com-
pared with the BCTs coded as delivered by the research-
ers. The CHARMS Educator will also record the number
of staff who attend the intervention and the number
who did not attend, as well as the duration of the inter-
vention. Fidelity of the staff intervention will be assessed
in both cardiac rehabilitation centres participating in
the CHARMS pilot by using the same standardised
methods and materials in each centre.
Fidelity of the CHARMS patient intervention: A checklist
will be developed for the distinct components of the
patient intervention. The staff member delivering the
patient intervention will review the checklist before deli-
vering the intervention (as a reminder of the compo-
nents to be delivered), and complete the checklist after
delivering the intervention (as a self-report of compo-
nents actually delivered). Patient attendance and dur-
ation of the intervention will be recorded by the staff
member. The staff member will also distribute exit ques-
tionnaires to patients at the end of the intervention.
Similar to the checklist provided to the staff member
delivering the intervention, these exit questionnaires will
ask patients to report on components delivered
(eg, ‘Did the staff member talk to your group about
communication techniques?’, allowing dichotomous
yes/no responses), and also ask patients to report on
how well they felt the components were delivered
(eg, ‘In your opinion, how well did the staff member
explain the use of communication techniques’, allowing
responses on a Likert-type scale). In this manner, patient
exit questionnaires will provide additional data on
adherence (supplementing the self-report data provided
by the staff member), and will also provide data on the
competence of the staff member in delivering the inter-
vention.45 As with the staff intervention, a more objective
measure of ﬁdelity will be provided by audio recording
the patient intervention, and then having two research-
ers independently code the recording for the presence
of the distinct components of the intervention.45 The
planned intervention components will be compared
with the components reported as delivered by the
CHARMS Educator, those reported as delivered by the
patients, and those coded as delivered by the research-
ers.46 Similarly, the planned BCTs will be compared with
the BCTs coded as delivered by the researchers. Fidelity
of the patient intervention will be assessed in both par-
ticipating cardiac rehabilitation centres by using the
same standardised methods and materials in each
centre.
To maximise ﬁdelity, the staff member will be provided
with an intervention pack that includes all materials
necessary to effectively deliver the patient intervention.
This pack will include predelivery and postdelivery
checklists, a staff manual, patient booklets and exit ques-
tionnaires for patients. To promote the maintenance of
skills and adherence to the intervention over time, the
research team will provide a number of supports. A
schedule of phone calls (eg, weekly or bimonthly)
between the research team and a designated member of
staff will be agreed upon, so that any issues related to
the intervention delivery can be reported, documented
and addressed. Staff members can request additional
intervention packs (by phone or online), and resources
such as manuals and training videos will be available for
download on the study website. The research team will
also document the details of how the CHARMS patient
intervention is incorporated into the cardiac rehabilita-
tion programme at each participating centre, the
number of contacts between staff and the research team
during the intervention, and the numbers of sex-related
queries, discussions and consultations recorded by staff
with patients. Fidelity of the intervention will also be
further explored in qualitative interviews conducted with
staff and patients, as described in more detail below.
Quantitative evaluation of feasibility and acceptability
We will document the number of invitations sent to
cardiac rehabilitation centres, the number of refusals
and the number of acceptances. We will document the
same for staff, patients and partners. Attrition (if any) of
centres, staff or patients/partners will be documented at
each data collection time point. Levels of missing data in
returned questionnaires will be reported. Questionnaires
administered to staff, patients and partners at all data
collection time points will include a comments section,
where participants will be invited to comment on the
comprehensibility and acceptability of the question-
naires, how the questionnaires might be improved, and
how long these took to complete.
Qualitative evaluation of feasibility, acceptability and fidelity
Using a descriptive qualitative methodology, all cardiac
rehabilitation staff will be invited to participate in semi-
structured interviews assessing their perspectives and
experiences of the CHARMS intervention. The interview
guide will include questions related to the experience of
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participating in the study, the feasibility and acceptability
of the study procedures, and the perceived effectiveness
of the intervention. Additionally, the interview guide will
further explore the ﬁdelity of the intervention, including
the nature of and rationale for any adaptations made to
the intervention, beliefs about the quality of interven-
tion delivery, the need for supports to maintain sexual
counselling skills over time and the identiﬁcation of add-
itional training needs. Staff members will be interviewed
at a single time point in the second half of the data col-
lection period. This will allow for sufﬁcient time to
ensure that staff have had experience of delivering the
patient intervention, and also experience handling
requests for one-to-one support from patients.
A qualitative longitudinal approach will be used to
capture patients’ perspectives and experiences of the
CHARMS intervention, and how and why these perspec-
tives and experiences change over time.47 Purposive
sampling will be employed by selecting patients for inter-
view based on data from the study measures, and use of
data from exit interviews administered at the end of the
patient intervention (eg, purposively sampling patients
with high and low SSPAQ scores, patients reporting and
not reporting organic sexual dysfunction, patients with
positive and negative evaluations in exit interviews, etc).
This will allow for maximum variation in the sample in
terms of demographic characteristics, study outcomes
and experiences of the intervention. Semistructured
interviews will be conducted with 30 patients in total, 15
from each participating centre. The 30 patients will be
interviewed at T2, and again at T3. Interviews at T2 will
explore the patients’ initial experiences of participating
in the study and initial usage of the intervention
content. Interviews at T3 will focus on ascertaining
patients’ use of the intervention content over time.
Qualitative analysis: Staff and patient interviews will be
transcribed verbatim and entered into the qualitative
analysis software program NVivo to facilitate data man-
agement, coding and retrieval. (NVivo qualitative data
analysis software [program]. 10 version, 2012). All data
will be initially open coded using thematic analysis, and
then axial coded to identify categories.48 Longitudinal
data from individual patients will be analysed within
time (ie, at T2 and then at T3), and also across time (ie,
comparing T2 to T3) to capture changes for these indi-
viduals. A thematic analysis of these changes will then be
produced, incorporating data from all patients. This lon-
gitudinal analysis will be guided by Holland et al.49 In
addition, the framework for the interrogation of longitu-
dinal qualitative data as proposed by Lewis,50 and
Saldaña’s51 guide to the qualitative analysis of change
through time will inform the analysis. The rigour of the
analysis will be maintained using the criteria of credibil-
ity, audibility, conﬁrmability and applicability.52
Statistical analysis
A study statistical database (using SPSS Data Collection
V.7 software) will be created by the study manager and
overseen by the study statistician; questionnaire responses
will be entered. Suitable graphical and numerical sum-
maries will be generated for the staff and patient mea-
sures at baseline. The aim of this pilot study is to inform
the development of a deﬁnitive trial; although the small
sample size will preclude effectiveness being established,
the primary outcome measure (SSPAQ) will be analysed
to mimic the deﬁnitive trial. Linear mixed models will be
used to model the longitudinal change for the primary
and secondary outcomes, while adjusting for cluster
membership and within-participant correlation over
time. Tree-based models for longitudinal responses will
be used to uncover potentially useful relationships in
data that may be informative when designing the deﬁni-
tive trial. All analyses of the primary outcome will be
treated as preliminary and interpreted with caution. An
estimate of the likely effect size will be calculated, as well
as an estimate of the intra-cluster correlation.
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